Mannkind (MNKD) Share-based Compensation (2010 - 2026)
Mannkind (MNKD) reported Share-based Compensation of $6.5 million for Q1 2026, up 19.87% year-over-year from $5.4 million in Q1 2025, and down 7.42% on a QoQ basis from $7.0 million in Q4 2025.
Mannkind (MNKD) has 17 years of Share-based Compensation data on file, last reported at $6.5 million in Q1 2026.
- Quarterly Share-based Compensation rose 19.87% year-over-year to $6.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.3 million (up 10.53% YoY) and the FY2025 annual result came in at $24.2 million, up 13.28% from the prior year.
- Share-based Compensation fell to $6.5 million in Q1 2026 per MNKD's latest filing, from $7.0 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $7.5 million in Q2 2025 and bottomed at $2.6 million in Q4 2022.
- The 5-year median for Share-based Compensation is $4.6 million (2023), against an average of $4.9 million.
- The widest annual swing landed in 2022, when Share-based Compensation dropped 17.82%; it then surged 52.58% in 2024.
- Tracing MNKD's Share-based Compensation over 5 years: stood at $2.6 million in 2022, then jumped by 46.82% to $3.8 million in 2023, then surged by 52.58% to $5.8 million in 2024, then advanced by 19.83% to $7.0 million in 2025, then decreased by 7.42% to $6.5 million in 2026.
- Per Business Quant, the three latest MNKD Share-based Compensation figures stand at $6.5 million (Q1 2026), $7.0 million (Q4 2025), and $4.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 6.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.46 Mn |
| Mar 31, 2026 | 6.46 Mn |
| Dec 31, 2025 | 6.97 Mn |
| Dec 31, 2025 | 6.97 Mn |
| Sep 30, 2025 | 4.32 Mn |
| Sep 30, 2025 | 4.32 Mn |
| Jun 30, 2025 | 7.52 Mn |
| Jun 30, 2025 | 7.52 Mn |
| Mar 31, 2025 | 5.39 Mn |
| Mar 31, 2025 | 5.39 Mn |
| Dec 31, 2024 | 5.82 Mn |
| Dec 31, 2024 | 5.82 Mn |
| Sep 30, 2024 | 5.23 Mn |
| Sep 30, 2024 | 5.23 Mn |
| Jun 30, 2024 | 6.43 Mn |
| Jun 30, 2024 | 6.43 Mn |
| Mar 31, 2024 | 3.89 Mn |
| Mar 31, 2024 | 3.89 Mn |
| Dec 31, 2023 | 3.81 Mn |
| Dec 31, 2023 | 3.81 Mn |
| Sep 30, 2023 | 4.60 Mn |
| Sep 30, 2023 | 4.60 Mn |
| Jun 30, 2023 | 5.58 Mn |
| Jun 30, 2023 | 5.58 Mn |
| Mar 31, 2023 | 3.66 Mn |
| Mar 31, 2023 | 3.66 Mn |
| Dec 31, 2022 | 2.60 Mn |
| Dec 31, 2022 | 2.60 Mn |
| Sep 30, 2022 | 3.62 Mn |
| Sep 30, 2022 | 3.62 Mn |
| Jun 30, 2022 | 4.42 Mn |
| Jun 30, 2022 | 4.42 Mn |
| Mar 31, 2022 | 2.81 Mn |
| Mar 31, 2022 | 2.81 Mn |
| Dec 31, 2021 | 3.16 Mn |
| Dec 31, 2021 | 3.16 Mn |
| Sep 30, 2021 | 3.18 Mn |
| Sep 30, 2021 | 3.18 Mn |
| Jun 30, 2021 | 3.93 Mn |
| Jun 30, 2021 | 3.93 Mn |
| Mar 31, 2021 | 1.94 Mn |
| Mar 31, 2021 | 1.94 Mn |
| Dec 31, 2020 | 1.90 Mn |
| Dec 31, 2020 | 1.90 Mn |
| Sep 30, 2020 | 1.29 Mn |
| Sep 30, 2020 | 1.29 Mn |
| Jun 30, 2020 | 2.19 Mn |
| Jun 30, 2020 | 2.19 Mn |
| Mar 31, 2020 | 1.13 Mn |
| Mar 31, 2020 | 1.13 Mn |
| Dec 31, 2019 | 891,000.00 |
| Dec 31, 2019 | 891,000.00 |
| Sep 30, 2019 | 1.64 Mn |
| Sep 30, 2019 | 1.64 Mn |
| Jun 30, 2019 | 2.57 Mn |
| Jun 30, 2019 | 2.57 Mn |
| Mar 31, 2019 | 999,000.00 |
| Mar 31, 2019 | 999,000.00 |
| Dec 31, 2018 | 1.14 Mn |
| Dec 31, 2018 | 1.14 Mn |
| Sep 30, 2018 | 1.56 Mn |
| Sep 30, 2018 | 1.56 Mn |
| Jun 30, 2018 | 2.21 Mn |
| Jun 30, 2018 | 2.21 Mn |
| Mar 31, 2018 | 1.94 Mn |
| Mar 31, 2018 | 1.94 Mn |
| Dec 31, 2017 | 1.08 Mn |
| Dec 31, 2017 | 1.08 Mn |
| Sep 30, 2017 | 1.25 Mn |
| Sep 30, 2017 | 1.25 Mn |
| Jun 30, 2017 | 1.25 Mn |
| Jun 30, 2017 | 1.25 Mn |
| Mar 31, 2017 | 1.27 Mn |
| Mar 31, 2017 | 1.27 Mn |
| Dec 31, 2016 | 1.01 Mn |
| Dec 31, 2016 | 1.01 Mn |
| Sep 30, 2016 | 1.50 Mn |
| Sep 30, 2016 | 1.50 Mn |
| Jun 30, 2016 | 1.36 Mn |
| Jun 30, 2016 | 1.36 Mn |
| Mar 31, 2016 | 1.30 Mn |
| Mar 31, 2016 | 1.30 Mn |
| Dec 31, 2015 | 2.35 Mn |
| Dec 31, 2015 | 2.35 Mn |
| Sep 30, 2015 | 2.60 Mn |
| Sep 30, 2015 | 2.60 Mn |
| Jun 30, 2015 | 1.78 Mn |
| Jun 30, 2015 | 1.78 Mn |
| Mar 31, 2015 | 2.00 Mn |
| Mar 31, 2015 | 2.00 Mn |
| Dec 31, 2014 | 1.87 Mn |
| Dec 31, 2014 | 1.87 Mn |
| Sep 30, 2014 | -4.83 Mn |
| Sep 30, 2014 | -4.83 Mn |
| Jun 30, 2014 | 40.64 Mn |
| Jun 30, 2014 | 40.64 Mn |
| Mar 31, 2014 | 5.20 Mn |
| Mar 31, 2014 | 5.20 Mn |
| Dec 31, 2013 | 13.88 Mn |
| Dec 31, 2013 | 13.88 Mn |
| Sep 30, 2013 | 15.94 Mn |
| Sep 30, 2013 | 15.94 Mn |
| Jun 30, 2013 | 10.17 Mn |
| Jun 30, 2013 | 10.17 Mn |
| Mar 31, 2013 | 5.19 Mn |
| Mar 31, 2013 | 5.19 Mn |
| Dec 31, 2012 | 3.52 Mn |
| Dec 31, 2012 | 3.52 Mn |
| Sep 30, 2012 | 3.82 Mn |
| Sep 30, 2012 | 3.82 Mn |
| Jun 30, 2012 | 3.07 Mn |
| Jun 30, 2012 | 3.07 Mn |
| Mar 31, 2012 | 2.88 Mn |
| Mar 31, 2012 | 2.88 Mn |
| Dec 31, 2011 | 3.18 Mn |
| Dec 31, 2011 | 3.18 Mn |
| Sep 30, 2011 | 3.32 Mn |
| Sep 30, 2011 | 3.32 Mn |
| Jun 30, 2011 | 1.99 Mn |
| Jun 30, 2011 | 1.99 Mn |
| Mar 31, 2011 | 2.71 Mn |
| Mar 31, 2011 | 2.71 Mn |
| Dec 31, 2010 | 2.24 Mn |
| Dec 31, 2010 | 2.24 Mn |
| Sep 30, 2010 | 3.34 Mn |
| Sep 30, 2010 | 3.34 Mn |